Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Higher iron levels in hair may increase the risk of esophageal cancer.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Pancreatic cancer can alter gut and skin bacteria, possibly causing skin issues.

Finasteride treats hair loss and reduces prostate cancer risk.

Certain genetic variants increase the risk of aggressive prostate cancer.

Fgfr2b helps maintain healthy skin and prevent cancer.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Green tea may help with health issues like cancer, heart disease, and weight loss due to its high catechin content.

Newly made nicotinamide compounds could potentially treat cancer.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.